2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide

C94H98F10N24O17 — CID 159028192

IUPAC2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide
SMILESCC1(NC(=O)Cn2nc(-c3ccc(OC(F)F)nc3)ccc2=O)CCC1.CCNC(=O)Cn1nc(-c2ccc(C3CC3)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OC(F)(F)F)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OCC(F)(F)F)nc2)ccc1=O.COc1ccc(-c2ccc(=O)n(CC(=O)NC(C)C)n2)cn1.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NC1CC12CC2
InChIInChI=1S/C17H16F2N4O3.C17H18F2N4O3.C16H18N4O2.C15H15F3N4O3.C15H18N4O3.C14H13F3N4O3/c18-16(19)26-14-3-1-10(8-20-14)11-2-4-15(25)23(22-11)9-13(24)21-12-7-17(12)5-6-17;1-17(7-2-8-17)21-13(24)10-23-15(25)6-4-12(22-23)11-3-5-14(20-9-11)26-16(18)19;1-2-17-15(21)10-20-16(22)8-7-14(19-20)12-5-6-13(18-9-12)11-3-4-11;1-2-19-12(23)8-22-14(24)6-4-11(21-22)10-3-5-13(20-7-10)25-9-15(16,17)18;1-10(2)17-13(20)9-19-15(21)7-5-12(18-19)11-4-6-14(22-3)16-8-11;1-2-18-11(22)8-21-13(23)6-4-10(20-21)9-3-5-12(19-7-9)24-14(15,16)17/h1-4,8,12,16H,5-7,9H2,(H,21,24);3-6,9,16H,2,7-8,10H2,1H3,(H,21,24);5-9,11H,2-4,10H2,1H3,(H,17,21);3-7H,2,8-9H2,1H3,(H,19,23);4-8,10H,9H2,1-3H3,(H,17,20);3-7H,2,8H2,1H3,(H,18,22)
InChIKeyJUNSDGKBQHKBTK-UHFFFAOYSA-N
MW2025.95 g/mol
LogP8.42
Rot. Bonds33

About 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide

2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide (PubChem CID 159028192) has the molecular formula C94H98F10N24O17 and a molecular weight of 2025.95 g/mol. Its IUPAC name is 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide.

Molecular Properties

Compound Name2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide
PubChem CID159028192
Molecular FormulaC94H98F10N24O17
Molecular Weight2025.95 g/mol
Exact Mass2024.74
IUPAC Name2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide
SMILESCC1(NC(=O)Cn2nc(-c3ccc(OC(F)F)nc3)ccc2=O)CCC1.CCNC(=O)Cn1nc(-c2ccc(C3CC3)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OC(F)(F)F)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OCC(F)(F)F)nc2)ccc1=O.COc1ccc(-c2ccc(=O)n(CC(=O)NC(C)C)n2)cn1.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NC1CC12CC2
InChIInChI=1S/C17H16F2N4O3.C17H18F2N4O3.C16H18N4O2.C15H15F3N4O3.C15H18N4O3.C14H13F3N4O3/c18-16(19)26-14-3-1-10(8-20-14)11-2-4-15(25)23(22-11)9-13(24)21-12-7-17(12)5-6-17;1-17(7-2-8-17)21-13(24)10-23-15(25)6-4-12(22-23)11-3-5-14(20-9-11)26-16(18)19;1-2-17-15(21)10-20-16(22)8-7-14(19-20)12-5-6-13(18-9-12)11-3-4-11;1-2-19-12(23)8-22-14(24)6-4-11(21-22)10-3-5-13(20-7-10)25-9-15(16,17)18;1-10(2)17-13(20)9-19-15(21)7-5-12(18-19)11-4-6-14(22-3)16-8-11;1-2-18-11(22)8-21-13(23)6-4-10(20-21)9-3-5-12(19-7-9)24-14(15,16)17/h1-4,8,12,16H,5-7,9H2,(H,21,24);3-6,9,16H,2,7-8,10H2,1H3,(H,21,24);5-9,11H,2-4,10H2,1H3,(H,17,21);3-7H,2,8-9H2,1H3,(H,19,23);4-8,10H,9H2,1-3H3,(H,17,20);3-7H,2,8H2,1H3,(H,18,22)
InChIKeyJUNSDGKBQHKBTK-UHFFFAOYSA-N
XLogP8.42
TPSA507.43 Ų
H-Bond Donors6
H-Bond Acceptors35
Rotatable Bonds33
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002025.95
LogP ≤ 58.42
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1035

Analyze 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(2S)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(2R)-butan-2-yl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-[(4-chlorophenyl)methyl]-2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-(2-propoxypyrimidin-5-yl)pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]pyridazin-1-yl]acetamide;N-cyclobutyl-2-[6-oxo-3-[2-[2-(trifluoromethoxy)ethoxy]pyrimidin-5-yl]pyridazin-1-yl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-[(2-methylphenyl)methyl]acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-phenylcyclobutyl)acetamide
CID 159013433
2-[3-[6-[cyclobutyl(methyl)amino]-3-pyridinyl]-6-oxopyridazin-1-yl]-N-ethylacetamide
CID 148562605
2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide
CID 153140345
2-(3-cyclopropyl-6-oxopyridazin-1-yl)-N-[(6-ethoxy-3-pyridinyl)methyl]acetamide
CID 122278642
N-ethyl-2-[3-[6-(6-oxa-3-azabicyclo[3.1.1]heptan-3-yl)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide
CID 147150407
N-cyclopentyl-2-[3-(4-fluorophenyl)-6-oxopyridazin-1-yl]acetamide
CID 3224412
2-(6-oxo-3-phenylpyridazin-1-yl)-N-propan-2-ylacetamide
CID 5057313
N-(1-bicyclo[1.1.1]pentanyl)-2-[3-[6-(1-bicyclo[1.1.1]pentanylamino)-3-pyridinyl]-6-oxopyridazin-1-yl]acetamide
CID 152897009
2-(3-cyclopropyl-6-oxopyridazin-1-yl)-N-propylacetamide
CID 122278444
2-[3-(4-ethylphenyl)-6-oxopyridazin-1-yl]-N-[4-(trifluoromethoxy)phenyl]acetamide
CID 8698992
N-ethyl-6-(2,2,2-trifluoroethoxy)pyridine-3-carboxamide
CID 70972173
cyclooctane;2-[3-(4-methoxyphenyl)-6-oxopyridazin-1-yl]-N-methylacetamide
CID 75366540

Frequently Asked Questions

What is the IUPAC name of 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide?
The IUPAC name of 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide (CID 159028192) is 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide.
What is the SMILES notation for 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide?
The canonical SMILES for 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide is CC1(NC(=O)Cn2nc(-c3ccc(OC(F)F)nc3)ccc2=O)CCC1.CCNC(=O)Cn1nc(-c2ccc(C3CC3)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OC(F)(F)F)nc2)ccc1=O.CCNC(=O)Cn1nc(-c2ccc(OCC(F)(F)F)nc2)ccc1=O.COc1ccc(-c2ccc(=O)n(CC(=O)NC(C)C)n2)cn1.O=C(Cn1nc(-c2ccc(OC(F)F)nc2)ccc1=O)NC1CC12CC2.
What is the InChIKey of 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide?
The InChIKey is JUNSDGKBQHKBTK-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H16F2N4O3.C17H18F2N4O3.C16H18N4O2.C15H15F3N4O3.C15H18N4O3.C14H13F3N4O3/c18-16(19)26-14-3-1-10(8-20-14)11-2-4-15(25)23(22-11)9-13(24)21-12-7-17(12)5-6-17;1-17(7-2-8-17)21-13(24)10-23-15(25)6-4-12(22-23)11-3-5-14(20-9-11)26-16(18)19;1-2-17-15(21)10-20-16(22)8-7-14(19-20)12-5-6-13(18-9-12)11-3-4-11;1-2-19-12(23)8-22-14(24)6-4-11(21-22)10-3-5-13(20-7-10)25-9-15(16,17)18;1-10(2)17-13(20)9-19-15(21)7-5-12(18-19)11-4-6-14(22-3)16-8-11;1-2-18-11(22)8-21-13(23)6-4-10(20-21)9-3-5-12(19-7-9)24-14(15,16)17/h1-4,8,12,16H,5-7,9H2,(H,21,24);3-6,9,16H,2,7-8,10H2,1H3,(H,21,24);5-9,11H,2-4,10H2,1H3,(H,17,21);3-7H,2,8-9H2,1H3,(H,19,23);4-8,10H,9H2,1-3H3,(H,17,20);3-7H,2,8H2,1H3,(H,18,22).
What are the key properties of 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide?
2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide has a molecular weight of 2025.95 g/mol, XLogP of 8.42, 33 rotatable bonds, 6 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-(6-cyclopropyl-3-pyridinyl)-6-oxopyridazin-1-yl]-N-ethylacetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-(1-methylcyclobutyl)acetamide;2-[3-[6-(difluoromethoxy)-3-pyridinyl]-6-oxopyridazin-1-yl]-N-spiro[2.2]pentan-2-ylacetamide;N-ethyl-2-[6-oxo-3-[6-(2,2,2-trifluoroethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;N-ethyl-2-[6-oxo-3-[6-(trifluoromethoxy)-3-pyridinyl]pyridazin-1-yl]acetamide;2-[3-(6-methoxy-3-pyridinyl)-6-oxopyridazin-1-yl]-N-propan-2-ylacetamide is sourced from PubChem (CID 159028192), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).